Pacific Biosciences (NQ: PACB )
13.49 +0.63 (+4.90%) Streaming Delayed Price Updated: 4:00 PM EDT, Jun 2, 2023 Add to My Watchlist
Headline News about Pacific Biosciences
Expert Ratings for Pacific Biosciences
May 04, 2023
Earnings Outlook For Pacific Biosciences
February 15, 2023
A pivotal week looks to be shaping up with the usual macro concerns arising, such as a Fed meeting and big earnings waiting just around the corner. One possible path to help navigate around these macro...
Despite a strong month and a great finish to the quarter, many traders remain cautious about the market. It’s been a volatile time after the collapse of Silicon Valley Bank, but the first quarter of...
When Small Cap Biotechs Lose Momentum: Are You An Investor Or A Trader?
February 05, 2023
A few small cap biotechs lost momentum last week so now might be the time to take profits. But many of these stocks are favored because of their core technology and favored by funds; time to buy?
Pacific Biosciences of California (PacBio) (NASDAQ: PACB) shares are trading higher today after the company announced it received orders for 76 Revio systems in the fourth quarter of 2022. The company...
Benzinga's Top Ratings Upgrades, Downgrades For January 5, 2023
January 05, 2023
12 Health Care Stocks Moving In Friday's Intraday Session
October 21, 2022
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following